Education
About Us
Working with TipRanks
Follow Us
Baker Bros. Advisors Lp Insider Profile
165 Followers
Baker Bros. Advisors Lp, Ten Percent Owner at BioCryst, holds 4.66M shares in Entrada Therapeutics Inc (Ticker: TRDA), holds 425.01K shares in KALA BIO (Ticker: KALA), holds 28.78M shares in Incyte (Ticker: INCY). Most recently, Baker Bros. Advisors Lp Bought ― shares of Entrada Therapeutics Inc on Nov 12, 2025 for an estimated value of $1.35M.
Baker Bros. Advisors Lp BioCryst (BCRX)Ten Percent Owner
BioCryst (BCRX)
Ten Percent Owner
Ranked #274 out of 104,310 Corporate Insiders
Profitable Transactions
53 out of 96 Profitable Transactions
Average Return
+27.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Baker Bros. Advisors Lp's holdings
Insider Roles
Roles that Baker Bros. Advisors Lp holds in companies
Most Profitable Insider Trade
Stock:
Invitae
(NVTAQ)
(NVTAQ)
Rating:Informative Buy
Date:Mar 29, 2018 - Mar 29, 2019
Return:+399.30%
The most profitable trade made by Baker Bros. Advisors Lp
Baker Bros. Advisors Lp's Trading History
BioCryst
Aug 16, 2016
Ten Percent Owner
Informative Sell
20.25M
$105.89M
Bellicum Pharmaceuticals
Nov 24, 2023
―
Uninformative Buy
―
$160.49K
BeOne Medicines
May 22, 2025
Director
Uninformative Buy
―
$3.13B
Aceragen
Jul 03, 2019
―
Uninformative Buy
15.47K
$1.65M
Alexion Pharmaceuticals
May 18, 2020
―
Uninformative Buy
―
$1.47B
Kiniksa Pharmaceuticals
Jun 05, 2025
Director
Uninformative Buy
―
$114.86M
Hookipa Pharma
Apr 23, 2019
Former 10% owner
Informative Buy
12.50M
$722.24K
Kodiak Sciences
Jun 06, 2022
Director, Ten Percent Owner
Informative Buy
4.45M
$312.80M
IGM Biosciences
Aug 18, 2025
―
Uninformative Sell
―
$0.00
Atreca
Oct 23, 2023
―
Informative Sell
109.90K
$267.40K
Zymeworks
―
Director
―
―
Prelude Therapeutics
Jan 29, 2021
Director, Ten Percent Owner
Uninformative Buy
133.33K
$14.80M
Spyre Therapeutics
―
Director
―
―
Talis Biomedical
Nov 19, 2021
Director, Ten Percent Owner
Informative Buy
218.00K
$12.20M
TScan Therapeutics
May 12, 2022
Director
Informative Buy
2.56M
$2.49M
Entrada Therapeutics Inc
Nov 12, 2025
Ten Percent Owner
Informative Buy
1.35M
$42.78M
DBV Technologies SA - American
Jun 13, 2022
Director, Ten Percent Owner
Uninformative Buy
―
$401.95M
Madrigal Pharmaceuticals
Aug 20, 2025
Director
Informative Buy
24.98M
$1.06B
vTv Therapeutics
Sep 05, 2025
Director
Uninformative Buy
―
$4.29M
Kymera Therapeutics
Jun 30, 2025
Director
Informative Buy
28.84M
$395.36M
Bicycle Therapeutics
Jan 06, 2025
Director, Ten Percent Owner
Uninformative Buy
―
$61.70M
Immunocore Holdings
Mar 19, 2025
Director
Informative Buy
23.99M
$83.64M
KALA BIO
Oct 02, 2025
Former 10% owner
Informative Sell
1.05M
$275.40K
Replimune Group
―
Director, Ten Percent Owner
―
―
Denali Therapeutics
Jun 05, 2025
Director
Uninformative Buy
―
$58.62M
Celcuity
Sep 10, 2025
Ten Percent Owner
Informative Buy
9.57M
$677.88M
Mirati Therapeutics
Nov 13, 2017
―
Informative Buy
2.20M
$2.13M
Neurogene
Oct 10, 2023
Director, Former 10% Owner
Uninformative Buy
―
$9.26M
Invitae
Mar 29, 2018
―
Informative Buy
5.00M
$83.09K
ACADIA Pharmaceuticals
Jun 02, 2025
Director, Ten Percent Owner
Uninformative Buy
―
$906.19M
Xoma
Jul 23, 2015
Former 10% owner
Informative Sell
11.99M
$2.88M
Genomic Health
Oct 03, 2019
―
Uninformative Buy
124.47K
$484.81M
Incyte
Oct 02, 2025
Director, Ten Percent Owner
Uninformative Buy
―
$2.93B
Seagen
Jun 02, 2023
―
Uninformative Buy
―
$9.84B
Synageva
―
―
―
―
List of latest transactions for each holding click on a transaction to see Baker Bros. Advisors Lp's performance on stock
You May Also Like
Baker Bros. Advisors Lp insider profile FAQ
What is the percentage of profitable transactions made by Baker Bros. Advisors Lp?
The percentage of profitable transactions made by Baker Bros. Advisors Lp is 55%.
What is the average return per transaction made by Baker Bros. Advisors Lp?
The average return per transaction made by Baker Bros. Advisors Lp is 27.20%.
What stocks does Baker Bros. Advisors Lp hold?
Baker Bros. Advisors Lp holds: BCRX, BLCM, ONC, ACGN, ALXN, KNSA, HOOK, KOD, IGMS, BCEL, ZYME, PRLD, SYRE, TLIS, TCRX, TRDA, DBVT, MDGL, VTVT, KYMR, BCYC, IMCR, KALA, REPL, DNLI, CELC, MRTX, NGNE, NVTAQ, ACAD, XOMA, GHDX, INCY, SGEN, GEVA stocks.
What was Baker Bros. Advisors Lp’s latest transaction?
Baker Bros. Advisors Lp latest transaction was an Informative Buy of $1.35M.
What was Baker Bros. Advisors Lp's most profitable transaction?
Baker Bros. Advisors Lp’s most profitable transaction was an Informative Buy of NVTAQ stock on March 29, 2018. The return on the trade was 399.30%.
What is Baker Bros. Advisors Lp's role in BioCryst?
Baker Bros. Advisors Lp's role in BioCryst is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.